SEC Form 4 · accession 0001435164-18-000002
CEREBAIN BIOTECH CORP. · CBBT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Clemons
Officer — President · Director
Period of report
Feb 19, 2018
Accepted (ET)
Sep 25, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453099
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 19, 2018 | A | 160,000 | $0.18 | A | 1,217,122 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person was issued the shares from the Issuer in lieu of compensation for services of $28,800.